Sidley announced that Corporate and Securities partner Steven Przesmicki has joined Sidley’s office in San Diego. Mr. Przesmicki joins from Cooley LLP, where he was a […]
Sidley Adds Corporate and Securities Partner Steven Przesmicki in San Diego
Sanofi to Acquire Dynavax Technologies in $2.2 Billion Deal
Weil Gotshal & Manges has advised Sanofi. Cooley has advised Dynavax Technologies. Sanofi has reached an agreement to acquire Dynavax Technologies Corporation, a publicly traded vaccines...
Lundbeck’s $2.6 Billion Acquisition of Longboard Pharmaceuticals
Baker McKenzie represented H.Lundbeck A/S (Lundbeck) in the transaction, Cooley represented Longboard Pharmaceuticals and Wilson Sonsini Goodrich & Rosati represented Evercore, Longboard’s financial advisor. H. Lundbeck...
Brightstar Capital’s $1.1 Billion Acquisition of PlayAGS
Kirkland & Ellis advised Brightstar Capital Partners on the transaction, and Cooley advised PlayAGS, Inc. Brightstar Capital Partners (“Brightstar”) has announced its $1.1 billion acquisition of...
Seven and Eight Biopharmaceuticals’ License Agreement with Eikon Therapeutics
Cooley advised Seven and Eight Biopharmaceuticals on the deal. Seven and Eight Biopharmaceuticals Inc. announced that it has signed an exclusive licensing agreement with Eikon Therapeutics....
Pfizer’s $6.7 Billion Acquisition of Arena Pharmaceuticals
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...